1Mommeja-Marin H,Mondon E,Blum RM,et al.Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection:Analysis and review of the literature[].Hepatology.2003
2Chen CJ,Yang HI,Su j,et al.Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level[].The Journal of The American Medical Association.2006
3Lawrence S,Thabut D,Zoulim F,et al.Sequential treatment with lamivudine and interferon monotherapies in patents with chronic hepatitis B not responding to interferon alone:Results of a pilot study[].Hepatology.2001
4Chen CJ,Yang HI,Su J,et al.Viral load is a strong predictor of liver cirrhosis risk in people chronically infected with hepatitis B virus regardless of hepatitis B e antigen status[].Journal of Hepatology.2005
5Lok ASF,McMahon BJ.AASLD practice guidline:Chronic hepatitis B[].Hepatology.2007
6Liaw YF,Leung N,Guan R,et al.Asian-Pacific consensus statement on management of chronic hepatitis B:An update[].Journal of Gastroenterology and Hepatology.2003
7Di Bisceglie AM,Lai CL,Gane E,et al.Telbivudine Globe trialmaximal early suppression is predictive of optimal two-year efficacy in nucleoside-treated hepatitis B patients[].Hepatology.